Fig. 6From: Mechanism of the blood pressure-lowering effect of sodium-glucose cotransporter 2 inhibitors in obese patients with type 2 diabetesThe clinical courses of four patients who could stop (A, B) or reduce (C, D) the amount of anti-hypertensive drugs. SBP, systolic blood pressure; DBP, diastolic blood pressure; HbA1C, glucosylated hemoglobinBack to article page